Terry Dagnon is the founder of Outlook Therapeutics. Backed by BioLexis. Based in Iselin, NJ.
Terry Dagnon serves as the Chief Operating Officer (COO) at Outlook Therapeutics. Outlook Therapeutics is a late clinical-stage biopharmaceutical company that focuses on developing ONS-5010/LYTENAVA for retinal indications. Dagnon is a public shareholder of the company and has sold 520,000 shares of its stock.
Full founder directory · Investor directory · Company funding database · Fundraising library